Nadia Khan

Nadia Khan is a neuroscientist joining Deciduous Therapeutics to explore the therapeutic potential of clearing senescent cells to treat age-related disorders. She received her PhD at the University of Wisconsin-Madison in Avtar Roopra's lab and completed her postdoctoral training in Tristan Shuman's lab at the Mount Sinai School of Medicine in New York City. Nadia's background and experience primarily comes from studying mechanisms of disease pathology in Epilepsy, using a variety of cell, molecular, animal behavior, animal modeling, in vivo imaging and electrophysiology techniques. Nadia comes to Deciduous Therapeutics after working as a Scientist II at CODA Biotherapeutics. She is looking forward to harnessing the power of the immune system to treat human diseases.